SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-003282
Filing Date
2019-01-10
Accepted
2019-01-10 17:09:39
Documents
2
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5973
2 POA DOCUMENT poa.txt EX-24.3_826263 3539
  Complete submission text file 0001209191-19-003282.txt   10822
Mailing Address 750 LEXINGTON AVE 20TH FL NEW YORK NY 10022
Business Address
BENTSUR RON (Reporting) CIK: 0001251213 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38079 | Film No.: 19520861

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations